OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
Adrian D. Hobson, Jianwen Xu, Dennie S. Welch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12544-12558
Closed Access | Times Cited: 13
Adrian D. Hobson, Jianwen Xu, Dennie S. Welch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 12544-12558
Closed Access | Times Cited: 13
Showing 13 citing articles:
Minimising the payload solvent exposed hydrophobic surface area optimises the antibody-drug conjugate properties
Adrian D. Hobson, Haizhong Zhu, Wei Qiu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 832-838
Closed Access | Times Cited: 5
Adrian D. Hobson, Haizhong Zhu, Wei Qiu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 832-838
Closed Access | Times Cited: 5
The medicinal chemistry evolution of antibody–drug conjugates
Adrian D. Hobson
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 809-831
Closed Access | Times Cited: 2
Adrian D. Hobson
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 809-831
Closed Access | Times Cited: 2
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation
Tomohiro Fujii, Kenichiro Ito, Kazutoshi Takahashi, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1767-1773
Open Access | Times Cited: 5
Tomohiro Fujii, Kenichiro Ito, Kazutoshi Takahashi, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1767-1773
Open Access | Times Cited: 5
Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala–Ala as the optimal dipeptide
Lu Wang, Adrian D. Hobson, Julia Fitzgibbons, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 355-365
Closed Access | Times Cited: 5
Lu Wang, Adrian D. Hobson, Julia Fitzgibbons, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 355-365
Closed Access | Times Cited: 5
Impact of drug-linker on method selection for analytical characterization and purification of antibody–drug conjugates
Ling C. Santora, Adrian D. Hobson, Lu Wang, et al.
Analytical Methods (2024) Vol. 16, Iss. 22, pp. 3492-3503
Closed Access | Times Cited: 1
Ling C. Santora, Adrian D. Hobson, Lu Wang, et al.
Analytical Methods (2024) Vol. 16, Iss. 22, pp. 3492-3503
Closed Access | Times Cited: 1
Anti-TNF Thioester Glucocorticoid Antibody–Drug Conjugate Fully Inhibits Inflammation with Minimal Effect on Systemic Corticosterone Levels in a Mouse Arthritis Model
Christopher C. Marvin, Adrian D. Hobson, Michael Mcpherson, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9495-9515
Closed Access | Times Cited: 1
Christopher C. Marvin, Adrian D. Hobson, Michael Mcpherson, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9495-9515
Closed Access | Times Cited: 1
Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154
Nathan B. Bennett, Xiaoqiang Shen, Bradley D. Gates, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2499-2517
Closed Access | Times Cited: 1
Nathan B. Bennett, Xiaoqiang Shen, Bradley D. Gates, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2499-2517
Closed Access | Times Cited: 1
Use of Impinging Jet to Improve Scalability in the Preparation of the ABBV-154 Drug-Linker
Nathan B. Bennett, Laurie B. Mlinar, Eric G. Moschetta, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2518-2533
Closed Access | Times Cited: 1
Nathan B. Bennett, Laurie B. Mlinar, Eric G. Moschetta, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2518-2533
Closed Access | Times Cited: 1
Discovery and Evaluation of TLR-Targeted Immune Agonists
Natalia Chernyak, Bhagyashree Bhagwat, Saraswathi Naravula, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16222-16234
Closed Access | Times Cited: 1
Natalia Chernyak, Bhagyashree Bhagwat, Saraswathi Naravula, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16222-16234
Closed Access | Times Cited: 1
Antibody drug conjugates beyond cytotoxic payloads
Adrian D. Hobson
Progress in medicinal chemistry (2023), pp. 1-59
Closed Access | Times Cited: 4
Adrian D. Hobson
Progress in medicinal chemistry (2023), pp. 1-59
Closed Access | Times Cited: 4
Linker substitution influences succinimide ring hydrolysis equilibrium impacting the stability of attachment to antibody–drug conjugates
L.C. Wang, Adrian D. Hobson, Paulin Salomon, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 612-622
Closed Access | Times Cited: 3
L.C. Wang, Adrian D. Hobson, Paulin Salomon, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 612-622
Closed Access | Times Cited: 3
Suzuki–Miyaura cross-coupling of unprotected ortho-bromoanilines with benzyl, alkyl, aryl, alkenyl and heteroaromatic boronic esters
Alexandra E. Lubaev, Christopher C. Marvin, Amanda W. Dombrowski, et al.
RSC Advances (2024) Vol. 14, Iss. 40, pp. 29184-29188
Open Access
Alexandra E. Lubaev, Christopher C. Marvin, Amanda W. Dombrowski, et al.
RSC Advances (2024) Vol. 14, Iss. 40, pp. 29184-29188
Open Access
Small molecule-drug conjugates: Mechanistic insights and strategic design for enhanced cancer therapy
Jiawei Zhu, Yucheng Xiong, Xiaoxue Bai, et al.
Chinese Chemical Letters (2024), pp. 110799-110799
Closed Access
Jiawei Zhu, Yucheng Xiong, Xiaoxue Bai, et al.
Chinese Chemical Letters (2024), pp. 110799-110799
Closed Access
